Duncan McKechnie, EVP, Chief Commercial Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 5,783 shares at $486.35 ($2.8M) on 2026-02-25, disclosed to the SEC on 2026-02-26.
Open-market sale of $2.8M VRTX by EVP, Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $485.11 | 873 | $424K | 15.0% |
| 2 | $486.35 | 2,500 | $1.2M | 43.1% |
| 3 | $489.00 | 2,410 | $1.2M | 41.8% |
| Total | $487.27 avg | 5,783 | $2.8M | 100% |
| Filing → |
| VRTX | SELL | 2026-03-06 | $1.2M | — | Filing → |